Govt plans to launch cheaper biosimilars for diabetes, cancer

The plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive
Source: Livemint.com (http://www.livemint.com/rss/industry)